SE7609719L - Forfarande for framstellning av kvaternera salter - Google Patents

Forfarande for framstellning av kvaternera salter

Info

Publication number
SE7609719L
SE7609719L SE7609719A SE7609719A SE7609719L SE 7609719 L SE7609719 L SE 7609719L SE 7609719 A SE7609719 A SE 7609719A SE 7609719 A SE7609719 A SE 7609719A SE 7609719 L SE7609719 L SE 7609719L
Authority
SE
Sweden
Prior art keywords
quaternera
salts
procedure
preparation
quaternera salts
Prior art date
Application number
SE7609719A
Other languages
English (en)
Other versions
SE429044B (sv
Inventor
D E Kuhla
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7609719L publication Critical patent/SE7609719L/sv
Publication of SE429044B publication Critical patent/SE429044B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/48Aldehydo radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7609719A 1975-09-03 1976-09-02 Analogiforfarande for framstellning av imidazo-pyridiniumsalter SE429044B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60991475A 1975-09-03 1975-09-03

Publications (2)

Publication Number Publication Date
SE7609719L true SE7609719L (sv) 1977-03-04
SE429044B SE429044B (sv) 1983-08-08

Family

ID=24442870

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609719A SE429044B (sv) 1975-09-03 1976-09-02 Analogiforfarande for framstellning av imidazo-pyridiniumsalter

Country Status (15)

Country Link
US (1) US4163745A (sv)
JP (1) JPS5233693A (sv)
AT (1) AT357158B (sv)
BE (1) BE845767A (sv)
CA (1) CA1063115A (sv)
DE (1) DE2634910C3 (sv)
DK (1) DK396676A (sv)
ES (1) ES451175A1 (sv)
FR (1) FR2322597A1 (sv)
GB (1) GB1519717A (sv)
IE (1) IE43313B1 (sv)
LU (1) LU75719A1 (sv)
MX (1) MX4817E (sv)
NL (1) NL7609772A (sv)
SE (1) SE429044B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173196B (it) * 1984-02-02 1987-06-18 Bellon Roger Schoum Rbs Pharma Composti imidazopiridinici farmacologicamente attivi
EP0375819A1 (en) * 1988-12-20 1990-07-04 Merrell Dow Pharmaceuticals Inc. Novel derivatives of 1,7'-[imidazo-[1,2-a]pyridine]5'-(6'H)ones
WO2004000841A1 (ja) * 2002-06-25 2003-12-31 Kyowa Hakko Kogyo Co., Ltd. 二環性複素環化合物
ES2522717B1 (es) * 2013-05-14 2015-06-24 Universidad De Alcalá Nuevos compuestos inhibidores de la proteina tirosina fosfatasa 1B

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1964282U (de) 1967-04-01 1967-07-20 Purrmann & Herr G M B H Wandler.
US3557114A (en) 1968-12-23 1971-01-19 Merck & Co Inc 1-substituted-3-(2-pyrimidinyl) imidazolium salts

Also Published As

Publication number Publication date
DK396676A (da) 1977-03-04
GB1519717A (en) 1978-08-02
ES451175A1 (es) 1977-09-01
CA1063115A (en) 1979-09-25
US4163745A (en) 1979-08-07
DE2634910B2 (de) 1979-11-22
FR2322597B1 (sv) 1980-04-25
JPS5437158B2 (sv) 1979-11-13
NL7609772A (nl) 1977-03-07
MX4817E (es) 1982-10-20
LU75719A1 (sv) 1977-06-15
DE2634910A1 (de) 1977-03-10
IE43313B1 (en) 1981-01-28
AT357158B (de) 1980-06-25
IE43313L (en) 1977-03-03
ATA653976A (de) 1979-11-15
JPS5233693A (en) 1977-03-14
SE429044B (sv) 1983-08-08
DE2634910C3 (de) 1980-08-14
FR2322597A1 (fr) 1977-04-01
BE845767A (fr) 1977-03-02

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE429961B (sv) Forfarande for framstellning av mjolksyra
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE7613565L (sv) Forfarande for framstellning av fusidinsyraderivat
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7609719L (sv) Forfarande for framstellning av kvaternera salter
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7607322L (sv) Forfarande for framstellning av 16-etrar av fusidinsyraderivat
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat